Literature DB >> 33883244

Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use.

Angelique E Boutzoukas1, Daniel K Benjamin2, Kanecia O Zimmerman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33883244      PMCID： PMC8085993          DOI： 10.1542/peds.2021-050212

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   9.703


× No keyword cloud information.
  8 in total

1.  Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.

Authors:  Anil R Maharaj; Huali Wu; Christoph P Hornik; Stephen J Balevic; Chi D Hornik; P Brian Smith; Daniel Gonzalez; Kanecia O Zimmerman; Daniel K Benjamin; Michael Cohen-Wolkowiez
Journal:  JAMA Pediatr       Date:  2020-10-05       Impact factor: 16.193

2.  Compassionate Use of Remdesivir in Children With Severe COVID-19.

Authors:  David L Goldman; Margaret L Aldrich; Stefan H F Hagmann; Alasdair Bamford; Andres Camacho-Gonzalez; Giuseppe Lapadula; Philip Lee; Paolo Bonfanti; Christoph C Carter; Yang Zhao; Laura Telep; Cheryl Pikora; Sarjita Naik; Neal Marshall; Ioannis Katsarolis; Moupali Das; Adam DeZure; Polly Desai; Huyen Cao; Anand P Chokkalingam; Anu Osinusi; Diana M Brainard; Ana Méndez-Echevarría
Journal:  Pediatrics       Date:  2021-04-21       Impact factor: 7.124

Review 3.  SARS-CoV-2 infections in children and young people.

Authors:  Susanna Felsenstein; Christian M Hedrich
Journal:  Clin Immunol       Date:  2020-09-06       Impact factor: 3.969

4.  Remdesivir for the Treatment of Covid-19 - Final Report.

Authors:  John H Beigel; Kay M Tomashek; Lori E Dodd; Aneesh K Mehta; Barry S Zingman; Andre C Kalil; Elizabeth Hohmann; Helen Y Chu; Annie Luetkemeyer; Susan Kline; Diego Lopez de Castilla; Robert W Finberg; Kerry Dierberg; Victor Tapson; Lanny Hsieh; Thomas F Patterson; Roger Paredes; Daniel A Sweeney; William R Short; Giota Touloumi; David Chien Lye; Norio Ohmagari; Myoung-Don Oh; Guillermo M Ruiz-Palacios; Thomas Benfield; Gerd Fätkenheuer; Mark G Kortepeter; Robert L Atmar; C Buddy Creech; Jens Lundgren; Abdel G Babiker; Sarah Pett; James D Neaton; Timothy H Burgess; Tyler Bonnett; Michelle Green; Mat Makowski; Anu Osinusi; Seema Nayak; H Clifford Lane
Journal:  N Engl J Med       Date:  2020-10-08       Impact factor: 91.245

5.  Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.

Authors:  Manli Wang; Ruiyuan Cao; Leike Zhang; Xinglou Yang; Jia Liu; Mingyue Xu; Zhengli Shi; Zhihong Hu; Wu Zhong; Gengfu Xiao
Journal:  Cell Res       Date:  2020-02-04       Impact factor: 25.617

Review 6.  Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19.

Authors:  Richard T Eastman; Jacob S Roth; Kyle R Brimacombe; Anton Simeonov; Min Shen; Samarjit Patnaik; Matthew D Hall
Journal:  ACS Cent Sci       Date:  2020-05-04       Impact factor: 14.553

7.  Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020.

Authors:  Lindsay Kim; Michael Whitaker; Alissa O'Halloran; Anita Kambhampati; Shua J Chai; Arthur Reingold; Isaac Armistead; Breanna Kawasaki; James Meek; Kimberly Yousey-Hindes; Evan J Anderson; Kyle P Openo; Andy Weigel; Patricia Ryan; Maya L Monroe; Kimberly Fox; Sue Kim; Ruth Lynfield; Erica Bye; Sarah Shrum Davis; Chad Smelser; Grant Barney; Nancy L Spina; Nancy M Bennett; Christina B Felsen; Laurie M Billing; Jessica Shiltz; Melissa Sutton; Nicole West; H Keipp Talbot; William Schaffner; Ilene Risk; Andrea Price; Lynnette Brammer; Alicia M Fry; Aron J Hall; Gayle E Langley; Shikha Garg
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-08-14       Impact factor: 17.586

Review 8.  The journey of remdesivir: from Ebola to COVID-19.

Authors:  Joe Pardo; Ashutosh M Shukla; Gajapathiraju Chamarthi; Asmita Gupte
Journal:  Drugs Context       Date:  2020-05-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.